News & Updates
The latest news and updates from companies in the WLTH portfolio.
TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies
TAG1 and NRG Pallas have signed a letter of intent to jointly develop access to lead-212 (Pb-212) for cancer drug development across Europe. This collaboration will combine TAG1's portable lead-212 generator with NRG Pallas' radium-224 (Ra-224) production capabilities. The agreement builds on an existing supply arrangement under which NRG Pallas will continue to deliver high-purity Ra-224 to TAG1 through 2028. Together, the firms intend to supply preclinical and clinical quantities of lead-212 to cancer drug developers across Europe, including hospital-based adult and pediatric oncology programs. The partnership is also exploring how its collaboration can support Lead4Life, a Dutch public-private initiative focused on developing lead-212-based radiopharmaceuticals and their supply chain.
TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies
TAG1 and NRG Pallas have signed a letter of intent to jointly develop access to lead-212 (Pb-212) for cancer drug development across Europe. This collaboration will combine TAG1's portable lead-212 generator with NRG Pallas' radium-224 (Ra-224) production capabilities. The agreement builds on an existing supply arrangement under which NRG Pallas will continue to deliver high-purity Ra-224 to TAG1 through 2028. Together, the firms intend to supply preclinical and clinical quantities of lead-212 to cancer drug developers across Europe, including hospital-based adult and pediatric oncology programs. The partnership is also exploring how its collaboration can support Lead4Life, a Dutch public-private initiative focused on developing lead-212-based radiopharmaceuticals and their supply chain.
TAG1 and NRG PALLAS to Expand Lead-212 Supply
TAG1 Inc. and NRG PALLAS B.V. sign LOI to advance access to Lead-212 for radiopharma cancer therapies across Europe. Together, TAG1 and NRG PALLAS will work to deliver pre-clinical and clinical quantities of Lead-212 to cancer drug innovators across Europe, including pioneering therapeutic companies and hospital-based adult and pediatric oncology programs. Under the LOI, the two organizations intend to combine TAG1's proprietary portable Lead-212 generator with NRG PALLAS' world-class Radium-224 production capabilities to meet the supply challenges facing the industry. The partnership will establish a secure, stable, and open supply platform for Lead-212 throughout Europe. "This milestone represents an important step in finding new cures for cancer," said Sumit Verma, President and CEO of TAG1. "By combining NRG PALLAS' experience and infrastructure with TAG1's portable generator, we believe we can accelerate the development of new Lead-212-based therapeutics for patients." "This LOI reflects our commitment to turning ambition into action," said Maurits Wolleswinkel, CEO of NRG PALLAS. "By joining forces with TAG1, we are taking a meaningful step toward making NRG PALLAS a leading supplier of Lead-212 in Europe and toward making the vision of the Lead4Life program a reality for patients." The Netherlands recently launched Lead4Life, an innovative public-private partnership focused on developing Lead-212-based radiopharmaceuticals, with significant emphasis on production and supply chain development. NRG PALLAS and TAG1 are actively exploring how their collaboration can accelerate the pathway from laboratory to patient within this broader initiative. About TAG1 Inc. About NRG PALLAS NRG PALLAS is a world leader in nuclear solutions, specializing in the production of medical isotopes and the development of advanced nuclear technologies. SOURCE TAG1, Inc. Market News and Data brought to you by Benzinga APIs To add Benzinga News as your preferred source on Google, click here.
Daily Dividend Report: PEBO,SMG,SO,NRG,CMS
Scotts Miracle-Gro, the leading marketer of branded consumer lawn and garden products in North America, announced that its Board of Directors has approved the payment of a cash dividend of $0.66 per share. The dividend is payable on Friday, June 5, 2026, to shareholders of record as of Friday, May 22, 2026. Southern today announced a regular quarterly dividend of 76 cents per share on the company's common stock, payable June 8, 2026 to shareholders of record as of May 18, 2026. In doing so, the company is increasing its dividend by 8 cents per share on an annualized basis to a rate of $3.04 per share. Every quarter for 79 consecutive years, Southern Company has paid a dividend to its shareholders that is equal to or greater than the previous quarter. NRG Energy today announced that its Board of Directors declared a quarterly dividend on the Company's common stock of $0.475 per share, or $1.90 per share on an annualized basis. The dividend is payable on May 15, 2026, to stockholders of record as of May 1, 2026. The Board of Directors of CMS Energy has declared a quarterly dividend on the company's common stock. The dividend for the common stock is 57 cents per share. It is payable May 29, 2026, to shareholders of record on May 8, 2026.
NRG Energy to Report First Quarter 2026 Financial Results on May 6, 2026 | Weekly Voice
HOUSTON-(BUSINESS WIRE)-NRG Energy, Inc. (NYSE:NRG) plans to report its first quarter 2026 financial results on Wednesday, May 6, 2026. Management will present the results during a conference call and webcast at 9:00 a.m. EST (8:00 a.m. CST). The company will issue a press release regarding the first quarter 2026 financial results prior to the conference call, and it will be available on the NRG website at www.nrg.com. The live webcast and presentation materials can be accessed at investors.n
NRG Energy board member Abraham to resign April 3
NRG Energy Inc. (NYSE: NRG) announced that board member E. Spencer Abraham will resign from the board of directors effective April 3, 2026, citing personal reasons. Abraham informed the board of his resignation intention on April 2, 2026. The company stated his decision was not due to any disagreement with the company, management, or the board regarding operations, policies, or practices. The resignation aligns with previously disclosed succession planning. Abraham was not standing for re-election at the company's annual stockholder meeting scheduled for April 30, 2026, according to the company's proxy statement filed with the Securities and Exchange Commission on March 18, 2026.
Lu-177 supply chain get boost with NRG Pallas, Morpho partnership
NRG Pallas and Global Morpho Pharma are partnering to establish an independent radiopharmaceutical supply chain for non-carrier-added (n.c.a.) lutetium-177 (Lu-177) chloride in Petten, the Netherlands. Under the agreement, Morpho's KaLupso automated radiochemistry platform will be deployed within NRG Pallas's nuclear infrastructure to produce GMP-grade n.c.a. Lu-177 chloride for Lu-177-based cancer therapies, according to the announcement. The location of NRG Pallas' reactor and processing facility on the same premises is designed to minimize isotope decay during transport and optimize yield, the companies said. The partnership aims to supply n.c.a. Lu-177 to a broad range of customers -- from established radiopharmaceutical companies to startups and public institutions -- through a nonexclusive model, the firms said. Installation, qualification, and validation of KaLupso within the GMP isotope production facility is currently underway, with initial commercial delivery targeted for early 2027.
EIX, ETR, NEE top chart as Utilities services gainers in Q1; CEG, NRG, VST among the losers (XLU:NYSEARCA)
Utilities Select Sector SPDR Fund ETF (XLU), which tracks the S&P 500 Utilities services sector, gained nearly 8.3% during the first quarter, outperforming the broader S&P 500 Index, which slipped nearly 4.8% during the same period. The utilities service sector, which XLU outperformed due to sector rotation favoring value stocks, average fund flow, and strong gains in specific utility companies. Top gainers were Edison International, Entergy, and NextEra Energy, while Constellation Energy and NRG Energy were notable losers; Gas and Multi-Utilities sub-sectors also led gains. Quant ratings rate XLU as a Buy based on expenses and dividends, but Seeking Alpha analysts are cautious; some expect XLU may underperform with potential price decline.
